Suppr超能文献

锂治疗患者的甲状腺疾病

Thyroid disorders in lithium-treated patients.

作者信息

Kirov G

机构信息

Division of Psychological Medicine, Heath Park, Cardiff, UK.

出版信息

J Affect Disord. 1998 Jul;50(1):33-40. doi: 10.1016/s0165-0327(98)00028-7.

Abstract

BACKGROUND

Little is known about the rate of thyroid disorders prior to lithium treatment, and which patients have a higher risk for developing such disorders during such treatment.

METHOD

Assessment of the thyroid histories and laboratory results of 209 lithium-treated patients with affective disorders from one catchment area.

RESULTS

Six female patients had thyrotoxicosis before starting lithium, a rate of 4.9%. Twenty patients developed hypothyroidism during the treatment: 3.4% of all males and 14.9% of all females. Female patients over the age of 50 were more likely to develop early lithium-induced hypothyroidism.

CONCLUSIONS

(1) Female patients with affective disorders might have an increased rate of thyrotoxicosis. (2) Lithium-induced hypothyroidism might develop earlier in female patients over the age of 50.

LIMITATIONS

Retrospective design of the study.

CLINICAL RELEVANCE

(1) The thyroid status of patients with affective disorders might be more relevant than is appreciated. (2) Guidelines for thyroid tests in lithium-treated patients should reflect the different risks conferred by age and gender.

摘要

背景

关于锂治疗前甲状腺疾病的发生率以及哪些患者在治疗期间发生此类疾病的风险较高,目前所知甚少。

方法

对来自一个集水区的209名接受锂治疗的情感障碍患者的甲状腺病史和实验室检查结果进行评估。

结果

6名女性患者在开始使用锂之前患有甲状腺毒症,发生率为4.9%。20名患者在治疗期间发生了甲状腺功能减退:所有男性中的发生率为3.4%,所有女性中的发生率为14.9%。50岁以上的女性患者更有可能早期发生锂诱导的甲状腺功能减退。

结论

(1)患有情感障碍的女性患者甲状腺毒症的发生率可能会增加。(2)50岁以上的女性患者可能更早发生锂诱导的甲状腺功能减退。

局限性

该研究为回顾性设计。

临床意义

(1)情感障碍患者的甲状腺状况可能比人们认识到的更重要。(2)锂治疗患者甲状腺检查的指南应反映年龄和性别所带来的不同风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验